Android app Apple app link

Neumora Therapeutics, Inc. Common Stock (NMRA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.92
Day's range
$3.25

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
07/13/2026 RBC Capital Brian Abrahams $5.00 $1.60   213.48%
01/12/2026 Leerink Partners Marc Goodman $8.00 $2.27   252.42%
01/05/2026 Mizuho Securities Graig Suvannavejh $6.00 $1.72   248.84%
01/02/2025 RBC Capital Brian Abrahams $4.00 $1.97   103.05%
07/22/2024 Needham Ami Fadia $23.00 $11.28   103.9%
07/08/2024 Mizuho Securities Graig Suvannavejh $20.00 $10.25   95.12%
06/17/2024 RBC Capital Brian Abrahams $29.00 $9.71   198.66%
03/13/2024 RBC Capital Brian Abrahams $31.00 $14.81   109.32%
10/10/2023 Stifel Nicolaus Paul Matteis $26.00 $10.91   138.31%
10/10/2023 RBC Capital Brian Abrahams $24.00 $10.91   119.98%

Neumora Therapeutics Inc. FAQ's

Neumora Therapeutics Inc. has been rated by research analysts at RBC Capital, Mizuho Securities, Leerink Partners, Needham, Stifel Nicolaus in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.